Skip to content
Screener

Biote Corp. BTMD EPS (Diluted)

EPS (Diluted) at other companies

Target logo
TargetTGT
$4.11+100%
Walmart logo
WalmartWMT
$0.80-9.1%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
-$0.19
BioLife Solutions logo
BioLife SolutionsBLFS
$0.91+376%
TEC
Bio-Techne Corp.TECH
$0.35
NAG
Niagen BioscienceNAGE
$0.07+16.7%

Other financials

Income statement

See full
Revenue$44.2M-9.5%
Gross profit$28.9M-17.3%
Operating income-$3.5M-133%
Net income-$6.6M-306%

Balance sheet

See full
Cash & equivalents$11.2M-43.0%
Total debt$128.6M+19.2%
Total equity-$65.8M+22.7%
Total assets$101.7M-3.0%

Cash flow

See full
Operating cash flow$3.9M-39.7%
CapEx$2.6M+41.3%
Free cash flow-$3.7M-171%

Valuation

See full
Market cap$44.45M-58.3%
Enterprise value$161.92M-16.9%
P/E7.6×+4.2×
P/S0.2×-0.3×

Profitability

See full
Gross margin68.6%-3.4pp
Operating margin8%-9.7pp
Net margin3.2%-12.5pp
FCF margin10.8%-6.7pp

Returns & leverage

See full
Return on equity1,123.5%
Debt / equity9.1×
Current ratio1.4×+0.5×

Where this comes from

Reported directly by Biote Corp. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Biote Corp.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:30 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-340364
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Other comprehensive income2945
Comprehensive income (loss)$(7,426)$3,934$(4,748)$19,769
Net income (loss) per common share
Basic$(0.23)$0.10$(0.14)$0.54
Diluted$(0.23)$0.10$(0.14)$0.46
Weighted average common shares outstanding
Basic28,626,13631,625,48529,630,66531,556,017
Diluted28,626,13631,743,16229,630,66536,959,274

Item 1. Financial Statements

FAQ

What is Biote Corp.'s EPS (diluted)?
Biote Corp. (BTMD) reported EPS (diluted) of -$0.23 in Q2 2026.
How has Biote Corp.'s EPS (diluted) changed year-over-year?
Biote Corp.'s EPS (diluted) decreased by 330.0% year-over-year, from $0.10 to -$0.23.
What is the long-term trend for Biote Corp.'s EPS (diluted)?
Over 3 years (2021 to 2025), Biote Corp.'s EPS (diluted) has grown at a 32.8% compound annual growth rate (CAGR), from $0.32 to $0.75.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Biote Corp.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude